Cyclin D3 restricts SARS-CoV-2 envelope incorporation into virions and interferes with viral spread

Ravi K Gupta1,2,3, Petra Mlcochova1,2

  • 1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.

The EMBO Journal
|September 26, 2022
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection degrades cyclin D3, a host protein. Depleting cyclin D3 enhances viral replication, suggesting a role in controlling SARS-CoV-2 assembly.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, highlights the need to understand host-virus interactions.
  • Host cell machinery is critical for viral replication and transmission.

Purpose of the Study:

  • To investigate the impact of SARS-CoV-2 infection on host cell cyclins.
  • To elucidate the role of specific cyclins in SARS-CoV-2 replication and assembly.

Main Methods:

  • Analyzing protein levels and localization (cyclins D1, D3) in SARS-CoV-2 infected cells.
  • Utilizing small-interfering RNA (siRNA) to knockdown cyclin D3.
  • Performing co-immunoprecipitation to identify protein interactions.

Main Results:

  • SARS-CoV-2 infection induced nuclear-to-cytoplasmic redistribution and proteasomal degradation of cyclin D1 and D3.
  • Cyclin D depletion was independent of SARS-CoV-2-induced cell cycle arrest.
  • Knockdown of cyclin D3 significantly increased progeny virus production.
  • Cyclin D3 was found to co-immunoprecipitate with SARS-CoV-2 E and M proteins.

Conclusions:

  • SARS-CoV-2 infection leads to the depletion of cyclin D3.
  • Cyclin D3 appears to inhibit the efficient assembly and release of new virions.
  • The degradation of cyclin D3 during infection may facilitate virus production.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a...
2.9K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.8K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
6.2K
Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
3.2K